MannKind Corp
MNKD
#6100
Rank
โ‚น109.13 B
Marketcap
โ‚น339.42
Share price
-1.12%
Change (1 day)
-29.05%
Change (1 year)

EPS for MannKind Corp (MNKD)

EPS in 2026 (TTM): -โ‚น6.50

According to MannKind Corp's latest financial reports the company's current EPS (TTM) is -โ‚น6.71. In 2025 the company made an earnings per share (EPS) of โ‚น1.92 a decrease over its 2024 EPS that were of โ‚น9.59.

EPS history for MannKind Corp from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น6.50-438.83%
2025โ‚น1.92-80%
2024โ‚น9.59
2022-โ‚น32.606.25%
2021-โ‚น30.6828%
2020-โ‚น23.97-7.41%
2019-โ‚น25.89
2017-โ‚น106.43-188.1%
2016โ‚น120.81-128.31%
2015-โ‚น426.6774.51%
2014-โ‚น244.49-20.31%
2013-โ‚น306.82-32.63%
2012-โ‚น455.43-28.03%
2011-โ‚น632.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น125.60-1,971.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
โ‚น411.84-6,236.29%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
โ‚น2,706-40,421.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น342.76-5,206.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
โ‚น279.97-4,271.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-โ‚น807.31 11,928.57%๐Ÿ‡บ๐Ÿ‡ธ USA